HBO1 determines SMAD action in pluripotency and mesendoderm specification
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkae158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Cong Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Immune Response and Immunotherapy, Joint School of Life Sciences, Guangzhou Institutes of Biomedicine and Health, Chinese Academy o…. Hauptthemen laut MEDLINE: Cell Differentiation, Histone Acetyltransferases, Mesoderm, Signal Transduction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, Health@InnoHK Program, Innovation Technology Commission of the Hong Kong SAR, P. R. China.
Abstract (Originalsprache)
TGF-β signaling family plays an essential role to regulate fate decisions in pluripotency and lineage specification. How the action of TGF-β family signaling is intrinsically executed remains not fully elucidated. Here, we show that HBO1, a MYST histone acetyltransferase (HAT) is an essential cell intrinsic determinant for TGF-β signaling in human embryonic stem cells (hESCs). HBO1−/− hESCs fail to response to TGF-β signaling to maintain pluripotency and spontaneously differentiate into neuroectoderm. Moreover, HBO1 deficient hESCs show complete defect in mesendoderm specification in BMP4-triggered gastruloids or teratomas. Molecularly, HBO1 interacts with SMAD4 and co-binds the open chromatin labeled by H3K14ac and H3K4me3 in undifferentiated hESCs. Upon differentiation, HBO1/SMAD4 co-bind and maintain the mesoderm genes in BMP4-triggered mesoderm cells while lose chromatin occupancy in neural cells induced by dual-SMAD inhibition. Our data reveal an essential role of HBO1, a chromatin factor to determine the action of SMAD in both human pluripotency and mesendoderm specification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Immune Response and Immunotherapy, Joint School of Life Sciences, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530,China; Guangzhou Medical University, Gua…
- Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangdong-Hong Kong Joint Laboratory for Stem Cell and Regenerative Medicine, Center for Cell Lineage and Cell Therapy, Guangzhou Institutes of…
- GIBH-HKU Guangdong-Hong Kong Stem Cell and Regenerative Medicine Research Centre, GIBH-CUHK Joint Research Laboratory on Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Acade…
- University of Chinese Academy of Sciences, Beijing 100049, China.
- Centre for Regenerative Medicine and Health, Hong Kong Institute of Science and Innovation, Chinese Academy of Sciences, Hong Kong.
ORCID-Profile: Guangjin Pan
Förderung
- National Key Research and Development Program of China
- Health@InnoHK Program
- Innovation Technology Commission of the Hong Kong SAR, P. R. China
- National Natural Science Foundation of China
- Science and Technology Planning Project of Guangdong Province
- Youth Innovation Promotion Association of the Chinese Academy of Sciences
- China Postdoctoral Science Foundation
- University of Chinese Academy of Sciences Education Foundation
Zitieren
APA
Zhang, C., Shan, Y., Lin, H., Zhang, Y., Xing, Q., Zhu, J., Zhou, T., Lin, A., Chen, Q., Wang, J., & Pan, G. (2024). HBO1 determines SMAD action in pluripotency and mesendoderm specification. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae158
Vancouver
Zhang C, Shan Y, Lin H, Zhang Y, Xing Q, Zhu J, et al. HBO1 determines SMAD action in pluripotency and mesendoderm specification. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae158
BibTeX
@article{Zhang2024,
author = {Zhang, Cong and Shan, Yongli and Lin, Huaisong and Zhang, Yanqi and Xing, Qi and Zhu, Jinmin and Zhou, Tiancheng and Lin, Aiping and Chen, Qianyu and Wang, Junwei and Pan, Guangjin},
title = {HBO1 determines SMAD action in pluripotency and mesendoderm specification},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkae158}
}
EUVIMED